Beta Bionics (BBNX) Reiterated at Buy by Stifel: Expecting Revenue Upside
Tweet Send to a Friend
Stifel analyst Jonathan Block reiterated a Buy rating and $31.00 price target on Beta Bionics, Inc. (NASDAQ: BBNX).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
